Table 1

Univariate analysis of clinical and pathological factors of intermediate risk patients with cervical carcinoma associated with recurrence and disease-specific survival.

VariableN=161 (%)5 years RFSp5 years DSSP value
Age (med, range)40 (20–76)
Stage

  •  IB1

  •  IB2

87 (54.0)
74 (46.0)		84.3%
89.0%		0.75490.5%
95.9%		0.534
Histologic type

  •  Squamous

  •  Non-squamous

114 (70.8)
47 (29.2)		89.2%
80.2%		0.0692.7%
85.9%		 0.055
DOI (fractional one-third)

  •  <1/3

  •  >1/3–<2/3

  •  >2/3

15 (6.2)
49 (30.4)
97 (63.4)		100%
85.2%
85.1%		0.244100%
93.8%
90.1%		0.325
LVSI

  •  No

  •  Yes

78 (48.4)
83 (51.6)		91.0%
82.2%		0.36797.4%
88.7%		0.562
Clinical tumor diameter (mm)

  •  <20

  •  20–39

  •  ≥40

3 (1.9)
53 (32.9)
105 (65.2)		100%
80.2%
89.3%		0.230100%
84.4%
97.1%		0.210

  • DOI, depth of invasion; DSS, disease-specific survival; LVSI, lymph vascular space invasion; RFS, recurrence-free survival.